left atrial ablation and pace and ablate therapy in atrial fibrillation (AF)
Last edited 05/2021 and last reviewed 05/2021
NICE atrial fibrillation guidance states (1):
- pace and ablate strategy
- consider pacing and atrioventricular node ablation for people with permanent atrial fibrillation with symptoms or left ventricular dysfunction thought to be caused by high ventricular rates
- when considering pacing and atrioventricular node ablation, reassess symptoms and the consequent need for ablation after pacing has been carried out and drug treatment further optimised
- consider left atrial catheter ablation before pacing and atrioventricular node ablation for people with paroxysmal atrial fibrillation or heart failure caused by non-permanent (paroxysmal or persistent) atrial fibrillation
- consider pacing and atrioventricular node ablation for people with permanent atrial fibrillation with symptoms or left ventricular dysfunction thought to be caused by high ventricular rates
- left atrial ablation
- if drug treatment is unsuccessful, unsuitable or not tolerated in people with symptomatic paroxysmal or persistent atrial fibrillation:
- consider radiofrequency point-by-point ablation or
- if radiofrequency point-by-point ablation is assessed as being unsuitable, consider cryoballoon ablation or laser balloon ablation
- consider left atrial surgical ablation at the same time as other cardiothoracic surgery for people with symptomatic atrial fibrillation
- if drug treatment is unsuccessful, unsuitable or not tolerated in people with symptomatic paroxysmal or persistent atrial fibrillation:
- preventing recurrence after ablation
- consider antiarrhythmic drug treatment for 3 months after left atrial ablation to prevent recurrence of atrial fibrillation, taking into account the person's preferences, and the risks and potential benefits
- reassess the need for antiarrhythmic drug treatment at 3 months after left atrial ablation
Reference: